in retatrutide, this effect is thought to be offset by the concurrent GLP-1 and GIP receptor agonism, which promote insulin secretion
That means cool temperatures (around 65F), blackout curtains, and screen-free wind-down time
This can lead to: Extreme fatigue and weakness Hair loss and brittle nails Electrolyte imbalances that affect heart rhythm A rebound weight gain once the diet ends because the metabolism has slowed down significantly If appetite suppression is making it harder to eat enough, GLP-1 Daily Support may be a helpful nutritional companion during treatment
If bloating is your main issue, raw cruciferous vegetables may feel rough at first
To experience a healthier gut and improved digestion during GLP-1 use, reach for Gut Responses cutting-edge GLP-1 Support formula
In the STEP 1 trial, semaglutide produced average weight loss of approximately 15% over 68 weeks, while the SURMOUNT-1 trial showed tirzepatide achieved 15-21% weight loss over 72 weeks